Biotech & Life Sciences FP&A

Pain Points We Eliminate

✗Pipeline NPV calculations done separately for each compound — no consolidated portfolio valuation view
✗Clinical trial burn rate not tracked in real-time — CRO invoices arrive weeks after costs incurred
✗Cash runway tied to milestones but no financial model connecting clinical events to liquidity

What We Deliver for Biotech & Life Sciences

✓Pipeline NPV and portfolio valuation modeling
✓Clinical trial cost tracking by phase and CRO
✓Milestone-based cash flow scenario modeling
✓Regulatory and FDA submission cost tracking
✓Out-licensing and royalty deal financial modeling
✓IP valuation and transfer pricing analysis

🔬

FP&A Intelligence

Biotech & Life Sciences

Pipeline NPV

Modeled Live

Burn

By Milestone

$12M

Capital Optimized

AI Activity — Real-Time

AI forecast updated — variance analysis ready2m

⚠ Budget variance detected — +$42K OpEx8m

Board report auto-generated & ready to send1h

Choose Your Path

How Does Your Biotech & Life Sciences Team Want to Work?

Both paths are purpose-built for Biotech & Life Sciences — choose the approach that best fits your team today.

📊 Excel-Enhanced FP&A

I Want to Stay in Excel
& Fill the Gaps

Keep every formula and model. Add AI automation, consolidation from 200+ sources, version control, and live dashboards — zero disruption to how you work today.